Actelion Pharmaceuticals US, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the brand name VELETRI� for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum ...

Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI� for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum ...

Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. � VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension and PAH associated with the scleroderma spectrum of ...

Tadalafil relaxes muscles and increases blood flow to particular areas of the body. Tadalafil is used to treat erectile dysfunction. Male impotence is a common problem worldwide. Treating it effectively with Tadalafil is one solution. Tadalafil is also used in both men and women to treat the symptoms of pulmonary arterial hypertension.

Researchers in the Faculty of Medicine & Dentistry at the University of Alberta are one step closer to a treatment for a deadly disease. Pulmonary arterial hypertension, which is high blood pressure in the lungs, currently has only a few treatment options but most cases lead to premature death. It is caused by a cancer-like excessive growth of cells in the wall of the lung blood vessels. It ...